|
1
|
Lauren P: The two histological main types
of gastric carcinoma: Diffuse and so-called intestinal-type
carcinoma. An attempt at a histo-clinical classification. Acta
Pathol Microbiol Scand. 64:31–49. 1965.PubMed/NCBI
|
|
2
|
Bass AJ, Thorsson V, Shmulevich I,
Reynolds SM, Miller M, Bernard B, Hinoue T, Laird PW, Curtis C,
Shen H, et al; Cancer Genome Atlas Research Network. Comprehensive
molecular characterization of gastric adenocarcinoma. Nature.
513:202–209. 2014. View Article : Google Scholar :
|
|
3
|
Fukayama M, Hino R and Uozaki H:
Epstein-Barr virus and gastric carcinoma: Virus-host interactions
leading to carcinoma. Cancer Sci. 99:1726–1733. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kaneda A, Matsusaka K, Aburatani H and
Fukayama M: Epstein-Barr virus infection as an epigenetic driver of
tumorigenesis. Cancer Res. 72:3445–3450. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Velho S, Fernandes MS, Leite M, Figueiredo
C and Seruca R: Causes and consequences of microsatellite
instability in gastric carcinogenesis. World J Gastroenterol.
20:16433–16442. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yamamoto H, Watanabe Y, Maehata T, Morita
R, Yoshida Y, Oikawa R, Ishigooka S, Ozawa S, Matsuo Y, Hosoya K,
et al: An updated review of gastric cancer in the next-generation
sequencing era: Insights from bench to bedside and vice versa.
World J Gastroenterol. 20:3927–3937. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kidd T, Bland KS and Goodman CS: Slit is
the midline repellent for the robo receptor in Drosophila. Cell.
96:785–794. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gara RK, Kumari S, Ganju A, Yallapu MM,
Jaggi M and Chauhan SC: Slit/Robo pathway: A promising therapeutic
target for cancer. Drug Discov Today. 20:156–164. 2015. View Article : Google Scholar :
|
|
9
|
Mehlen P, Delloye-Bourgeois C and Chédotal
A: Novel roles for Slits and netrins: Axon guidance cues as
anticancer targets? Nat Rev Cancer. 11:188–197. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Prasad A, Paruchuri V, Preet A, Latif F
and Ganju RK: Slit-2 induces a tumor-suppressive effect by
regulating beta-catenin in breast cancer cells. J Biol Chem.
283:26624–26633. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shi R, Yang Z, Liu W, Liu B, Xu Z and
Zhang Z: Knockdown of Slit2 promotes growth and motility in gastric
cancer cells via activation of AKT/β-catenin. Oncol Rep.
31:812–818. 2014.
|
|
12
|
Dallol A, Da Silva NF, Viacava P, Minna
JD, Bieche I, Maher ER and Latif F: SLIT2, a human homologue of the
Drosophila Slit2 gene, has tumor suppressor activity and is
frequently inactivated in lung and breast cancers. Cancer Res.
62:5874–5880. 2002.PubMed/NCBI
|
|
13
|
Dickinson RE, Dallol A, Bieche I, Krex D,
Morton D, Maher ER and Latif F: Epigenetic inactivation of SLIT3
and SLIT1 genes in human cancers. Br J Cancer. 91:2071–2078. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Narayan G, Goparaju C, Arias-Pulido H,
Kaufmann AM, Schneider A, Dürst M, Mansukhani M, Pothuri B and
Murty VV: Promoter hypermethylation-mediated inactivation of
multiple Slit-Robo pathway genes in cervical cancer progression.
Mol Cancer. 5:162006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu YF, Zhang L, Waye MM, Fu WM and Zhang
JF: MiR-218 mediates tumorigenesis and metastasis: Perspectives and
implications. Exp Cell Res. 334:173–182. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tatarano S, Chiyomaru T, Kawakami K,
Enokida H, Yoshino H, Hidaka H, Yamasaki T, Kawahara K, Nishiyama
K, Seki N, et al: miR-218 on the genomic loss region of chromosome
4p15.31 functions as a tumor suppressor in bladder cancer. Int J
Oncol. 39:13–21. 2011.PubMed/NCBI
|
|
17
|
Alajez NM, Lenarduzzi M, Ito E, Hui AB,
Shi W, Bruce J, Yue S, Huang SH, Xu W, Waldron J, et al: MiR-218
suppresses nasopharyngeal cancer progression through downregulation
of survivin and the SLIT2-ROBO1 pathway. Cancer Res. 71:2381–2391.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tie J, Pan Y, Zhao L, Wu K, Liu J, Sun S,
Guo X, Wang B, Gang Y, Zhang Y, et al: MiR-218 inhibits invasion
and metastasis of gastric cancer by targeting the Robo1 receptor.
PLoS Genet. 6:e10008792010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim M, Kim JH, Jang HR, Kim HM, Lee CW,
Noh SM, Song KS, Cho JS, Jeong HY, Hahn Y, et al: LRRC3B, encoding
a leucine-rich repeat-containing protein, is a putative tumor
suppressor gene in gastric cancer. Cancer Res. 68:7147–7155. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim M, Park YK, Kang TW, Lee SH, Rhee YH,
Park JL, Kim HJ, Lee D, Lee D, Kim SY, et al: Dynamic changes in
DNA methylation and hydroxymethylation when hES cells undergo
differentiation toward a neuronal lineage. Hum Mol Genet.
23:657–667. 2014. View Article : Google Scholar
|
|
21
|
Haam K, Kim HJ, Lee KT, Kim JH, Kim M, Kim
SY, Noh SM, Song KS and Kim YS: Epigenetic silencing of BTB and CNC
homology 2 and concerted promoter CpG methylation in gastric
cancer. Cancer Lett. 351:206–214. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim SK, Jang HR, Kim JH, Kim M, Noh SM,
Song KS, Kang GH, Kim HJ, Kim SY, Yoo HS, et al: CpG methylation in
exon 1 of transcription factor 4 increases with age in normal
gastric mucosa and is associated with gene silencing in
intestinal-type gastric cancers. Carcinogenesis. 29:1623–1631.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jones PA and Taylor SM: Cellular
differentiation, cytidine analogs and DNA methylation. Cell.
20:85–93. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lokk K, Modhukur V, Rajashekar B, Märtens
K, Mägi R, Kolde R, Koltšina M, Nilsson TK, Vilo J, Salumets A, et
al: DNA methylome profiling of human tissues identifies global and
tissue-specific methylation patterns. Genome Biol. 15:r542014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nazor KL, Altun G, Lynch C, Tran H,
Harness JV, Slavin I, Garitaonandia I, Müller FJ, Wang YC, Boscolo
FS, et al: Recurrent variations in DNA methylation in human
pluripotent stem cells and their differentiated derivatives. Cell
Stem Cell. 10:620–634. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wong SS, Kim KM, Ting JC, Yu K, Fu J, Liu
S, Cristescu R, Nebozhyn M, Gong L, Yue YG, et al: Genomic
landscape and genetic heterogeneity in gastric adenocarcinoma
revealed by whole-genome sequencing. Nat Commun. 5:54772014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Biankin AV, Waddell N, Kassahn KS, Gingras
MC, Muthuswamy LB, Johns AL, Miller DK, Wilson PJ, Patch AM, Wu J,
et al; Australian Pancreatic Cancer Genome Initiative. Pancreatic
cancer genomes reveal aberrations in axon guidance pathway genes.
Nature. 491:399–405. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Peifer M, Fernández-Cuesta L, Sos ML,
George J, Seidel D, Kasper LH, Plenker D, Leenders F, Sun R, Zander
T, et al: Integrative genome analyses identify key somatic driver
mutations of small-cell lung cancer. Nat Genet. 44:1104–1110. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li Q, Zhu F and Chen P: miR-7 and miR-218
epigenetically control tumor suppressor genes RASSF1A and Claudin-6
by targeting HoxB3 in breast cancer. Biochem Biophys Res Commun.
424:28–33. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tu Y, Gao X, Li G, Fu H, Cui D, Liu H, Jin
W and Zhang Y: MicroRNA-218 inhibits glioma invasion, migration,
proliferation, and cancer stem-like cell self-renewal by targeting
the polycomb group gene Bmi1. Cancer Res. 73:6046–6055. 2013.
View Article : Google Scholar : PubMed/NCBI
|
